← Leaderboards
Josyf Mychaleckyj
Wake Forest University Health Sciences
$1,142,418
Attributed
$3,066,673
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $899.1K · FY2019–23$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,066,673 · 3
By mechanism
R01$3,066,673 · 2
P30$0 · 1
Top collaborators
- Fern R Hauck4 shared
- Keith L Keene4 shared
- Thu H Le3 shared
Most similar at Wake Forest University Health Sciences
Same institution · by research overlap
- Jeff Douglas Williamson$16,761,474
- David Reboussin$26,999,221
- David Goff$10,722,408
- Alain Gerald Bertoni$7,277,999
- Keith L Keene$1,520,920
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectGeneticPlasmaEuropeanCessation Of LifeGenesFunctional DisorderGenetic AnalysisPathway InteractionsAfrican AmericanVariantHigh RiskCohortCodePhenotypeGene ExpressionClinical DiagnosticsAmerican IndiansChildhoodClinicCohort StudiesBiological MarkersCardiovascular SystemCause Of Death
Grant awards (8)
Using Integrative Omics as Biomarkers and Diagnostic Tools for SIDS$435,558
R01 · FY2023 · HD
Using Integrative Omics as Biomarkers and Diagnostic Tools for SIDS$584,495
R01 · FY2022 · HD
Using Integrative Omics as Biomarkers and Diagnostic Tools for SIDS$663,257
R01 · FY2021 · HD
GSTM1, APOL1, and their joint contribution to severity of hypertension and chronic kidney disease$235,887
R01 · FY2021 · DK
Using Integrative Omics as Biomarkers and Diagnostic Tools for SIDS$662,202
R01 · FY2020 · HD
GSTM1, APOL1, and their joint contribution to severity of hypertension and chronic kidney disease$235,887
R01 · FY2020 · DK
GSTM1, APOL1, and their joint contribution to severity of hypertension and chronic kidney disease$249,387
R01 · FY2019 · DK
THE GENETIC CONTRIBUTION TO MUSCLE MASS AND PERFORMANCE IN AGING HUMANS$0
P30 · FY2002 · AG